Palatin Technologies (OTCMKTS:PTNT) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell?
by Teresa Graham · The Cerbat GemPalatin Technologies, Inc. (OTCMKTS:PTNT – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $7.31 and traded as high as $25.53. Palatin Technologies shares last traded at $25.53, with a volume of 2 shares traded.
Palatin Technologies Stock Down 1.0%
The business’s fifty day moving average is $10.84 and its 200 day moving average is $7.43. The firm has a market capitalization of $24.60 million, a price-to-earnings ratio of -16.31 and a beta of 0.75.
Palatin Technologies Company Profile
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy.